ENDRA Capex To Revenue from 2010 to 2024

NDRA Stock  USD 6.05  0.21  3.60%   
ENDRA Life's Capex To Revenue is increasing over the years with slightly volatile fluctuation. Overall, Capex To Revenue is expected to go to 15.31 this year. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
14.58
Current Value
15.31
Quarterly Volatility
8.02428964
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ENDRA Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ENDRA Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 289.2 K, Interest Expense of 23.5 K or Selling General Administrative of 3.7 M, as well as many indicators such as Price To Sales Ratio of 1.8 M, Dividend Yield of 0.0 or PTB Ratio of 5.6 K. ENDRA financial statements analysis is a perfect complement when working with ENDRA Life Valuation or Volatility modules.
  
Check out the analysis of ENDRA Life Correlation against competitors.

Latest ENDRA Life's Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of ENDRA Life Sciences over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. ENDRA Life's Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ENDRA Life's overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

ENDRA Capex To Revenue Regression Statistics

Arithmetic Mean7.57
Geometric Mean1.48
Coefficient Of Variation106.07
Mean Deviation7.72
Median0.49
Standard Deviation8.02
Sample Variance64.39
Range16.1746
R-Value0.85
Mean Square Error19.70
R-Squared0.72
Significance0.00007
Slope1.52
Total Sum of Squares901.45

ENDRA Capex To Revenue History

2024 15.31
2023 14.58
2018 16.2
2016 0.0224
2015 0.0949

About ENDRA Life Financial Statements

ENDRA Life stakeholders use historical fundamental indicators, such as ENDRA Life's Capex To Revenue, to determine how well the company is positioned to perform in the future. Although ENDRA Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in ENDRA Life's assets and liabilities are reflected in the revenues and expenses on ENDRA Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ENDRA Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Revenue 14.58  15.31 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out the analysis of ENDRA Life Correlation against competitors.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
-3 K
Return On Assets
(0.61)
Return On Equity
(1.20)
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.